{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:44Z","timestamp":1792786124657,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["PI22\/01804"],"award-info":[{"award-number":["PI22\/01804"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["Q123RSV79"],"award-info":[{"award-number":["Q123RSV79"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neurogastroenterology and Motility"},{"DOI":"10.13039\/100031734","name":"Spanish Association of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Patients with systemic sclerosis present with severe gastroesophageal reflux disease, often refractory to proton-pump inhibitors (PPI) treatment. The aim of the present study was to identify factors associated with PPI-refractory oesophagitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a cross-sectional study in a single-centre cohort of patients diagnosed with systemic sclerosis. We included patients who underwent an oesophagogastroduodenoscopy while on PPI treatment. Patients with PPI-refractory erosive oesophagitis were compared with those with endoscopically normal oesophageal mucosa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 69 patients were included. From these, 23 patients (33%) had PPI-refractory oesophagitis (Grade A, n\u2009=\u200911; Grade B, n\u2009=\u20097; Grade C, n\u2009=\u20092; Grade D, n\u2009=\u20093) and 46 (67%) had an endoscopically normal oesophageal mucosa. On univariate analysis, patients with PPI-refractory oesophagitis were more frequently diffuse SSc subset (43% vs 17%; P\u2009=\u20090.041). Evaluating gastrointestinal motility tests, neither absent oesophageal contractility (39% vs 25%, P\u2009=\u20090.292) nor hypotensive lower oesophageal sphincter (47% vs 44%, P\u2009=\u20090.980) were significantly associated with PPI-refractory oesophagitis. Gastrointestinal dysmotility, defined as abnormal gastric emptying and\/or small bowel dilated loops, was significantly associated with PPI-refractory oesophagitis (66 vs 8%, P\u2009=&amp;lt;0.001). On a multivariate regression model to evaluate the association between motility test results adjusted for the diffuse subset, gastrointestinal dysmotility (\u03b2\u2009=\u20090.751, P\u2009=\u20090.010) was independently associated with PPI-refractory oesophagitis, while absent oesophageal contractility (\u03b2\u2009=\u20090.044, P\u2009=\u20090.886) or a hypotensive LES were not (\u03b2\u2009=\u2009\u22120.131, P\u2009=\u20090.663).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that gastric and small intestinal motor dysfunction may be an important contributor to the development of PPI-refractory oesophagitis in patients with systemic sclerosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae481","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:27:51Z","timestamp":1725618471000},"page":"3074-3079","source":"Crossref","is-referenced-by-count":20,"title":["Gastrointestinal dysmotility is associated with proton pump inhibitor refractory oesophagitis in patients with systemic sclerosis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-1539","authenticated-orcid":false,"given":"Luis G","family":"Alcala-Gonzalez","sequence":"first","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0626-507X","authenticated-orcid":false,"given":"Alfredo","family":"Guillen-del-Castillo","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Department of Medicine, Universitat Autonoma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-311X","authenticated-orcid":false,"given":"Ariadna","family":"Aguilar Cayuelas","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4711-2731","authenticated-orcid":false,"given":"Claudia","family":"Barber Caselles","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-5897","authenticated-orcid":false,"given":"Claudia","family":"Codina-Clavaguera","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-5139","authenticated-orcid":false,"given":"Antonio","family":"Marin Garc\u00eda","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2120-6270","authenticated-orcid":false,"given":"Jordi","family":"Serra","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd)"},{"name":"Department of Medicine, Universitat Autonoma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7097-1492","authenticated-orcid":false,"given":"Carolina","family":"Malagelada","sequence":"additional","affiliation":[{"name":"Digestive System Research Unit, Department of Digestive Diseases, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (Ciberehd)"},{"name":"Department of Medicine, Universitat Autonoma de Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-9029","authenticated-orcid":false,"given":"Carmen P","family":"Sime\u00f3n-Aznar","sequence":"additional","affiliation":[{"name":"Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d\u2019Hebron University Hospital , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"2025050316124444500_keae481-B1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41584-023-00929-1","article-title":"Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management","volume":"19","author":"McMahan","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025050316124444500_keae481-B2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-023-00883-z","article-title":"Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management","volume":"21","author":"Arg\u00fcero","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025050316124444500_keae481-B3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/gastro\/goaa096","article-title":"Higher risk of neoplastic progression of Barrett\u2019s esophagus in patients with systemic sclerosis","volume":"9","author":"Anilkumar","year":"2021","journal-title":"Gastroenterol Rep"},{"key":"2025050316124444500_keae481-B4","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/S2665-9913(22)00183-7","article-title":"Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease","volume":"4","author":"Hughes","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2025050316124444500_keae481-B5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mcna.2018.08.002","article-title":"Proton pump inhibitor-refractory gastroesophageal reflux disease","volume":"103","author":"Yadlapati","year":"2019","journal-title":"Med Clin North Am"},{"key":"2025050316124444500_keae481-B6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1365-2036.2006.03180.x","article-title":"Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy","volume":"24","author":"Marie","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2025050316124444500_keae481-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox067","article-title":"Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification","volume":"30","author":"Aggarwal","year":"2017","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"issue":"Suppl 100","key":"2025050316124444500_keae481-B8","first-page":"115","article-title":"High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity","volume":"34","author":"Raja","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025050316124444500_keae481-B9","first-page":"kead520","article-title":"Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis","author":"Perurena-Prieto","year":"2023","journal-title":"Rheumatology"},{"key":"2025050316124444500_keae481-B10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"key":"2025050316124444500_keae481-B11","doi-asserted-by":"crossref","first-page":"e14058","DOI":"10.1111\/nmo.14058","article-title":"Esophageal motility disorders on high-resolution manometry: chicago classification version 4.0\u00a9","volume":"33","author":"Yadlapati","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"2025050316124444500_keae481-B12","doi-asserted-by":"crossref","first-page":"e14643","DOI":"10.1111\/nmo.14643","article-title":"Distinctive gastrointestinal motor dysfunction in patients with MNGIE","volume":"35","author":"Alcal\u00e1-Gonz\u00e1lez","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"2025050316124444500_keae481-B13","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1093\/rheumatology\/kead486","article-title":"Significant gastrointestinal unmet needs in patients with Systemic Sclerosis: insights from a large international patient survey","volume":"63","author":"Bandini","year":"2024","journal-title":"Rheumatology"},{"key":"2025050316124444500_keae481-B14","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1529-0131(199810)41:10<1874::AID-ART21>3.0.CO;2-T","article-title":"Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study","volume":"41","author":"Marie","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2025050316124444500_keae481-B15","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1093\/rheumatology\/keac074","article-title":"Gastroparesis in systemic sclerosis: a detailed analysis using whole-gut scintigraphy","volume":"61","author":"Adler","year":"2022","journal-title":"Rheumatology"},{"key":"2025050316124444500_keae481-B16","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.3390\/nu12113536","article-title":"Gastroesophageal reflux disease and foregut dysmotility in children with intestinal failure","volume":"12","author":"Rybak","year":"2020","journal-title":"Nutrients"},{"key":"2025050316124444500_keae481-B17","doi-asserted-by":"crossref","first-page":"13247","DOI":"10.1111\/nmo.13247","article-title":"Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients","volume":"30","author":"Stern","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"2025050316124444500_keae481-B18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.25280","article-title":"A multinational survey investigating the unmet needs and patient perspectives concerning proton pump inhibitors in systemic sclerosis","volume":"76","author":"Bandini","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2025050316124444500_keae481-B19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-017-1340-y","article-title":"Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study","volume":"19","author":"Vigone","year":"2017","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae481\/59462460\/keae481.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3074\/59462460\/keae481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3074\/59462460\/keae481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T16:13:00Z","timestamp":1746288780000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/3074\/7754086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9,9]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae481","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,9,9]]}}}